FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1459454017 Cutaneous AND/OR transdermal dosage form (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    161731000077114 forme pharmaceutique pour usage transdermique et/ou cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
    161731000077114 forme pharmaceutique pour usage transdermique et/ou cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    forme pharmaceutique pour usage transdermique et/ou cutané Is a Type of drug preparation false Inferred relationship Existential restriction modifier (core metadata concept)
    forme pharmaceutique pour usage transdermique et/ou cutané Is a Dose form by site prepared for (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Coal tar extract 2% shampoo (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Selenium sulfide 25 mg/mL shampoo Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Alcoholic coal tar extract 5% shampoo (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Coal tar 4.3% shampoo (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Salicylic acid 20 mg/mL cutaneous lotion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Lithium succinate 80 mg/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Lithium succinate 8% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Chloramphenicol DTF 1% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Colistin sulfate topical powder Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Mupirocin (as mupirocin calcium) 20 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Mupirocin 20 mg/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin 0.5% cream BPC Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Silver sulfadiazine 1% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Fusidic acid 20 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzoyl peroxide 50 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone+clotrimazole 0.05/1% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release cutaneous spray (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Clotrimazole 1% dusting powder Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Econazole nitrate 10 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Ketoconazole 20 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole nitrate 20 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole nitrate 2% dusting powder Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely miconazole nitrate 1.6 milligram/1 gram conventional release powder for cutaneous spray (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin 100000 unit/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin 100000 unit/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely sulconazole nitrate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Undecylenic acid 50 mg/mL and zinc undecylenate 200 mg/mL cutaneous spray Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Metronidazole 7.5 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Metronidazole 10 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Amorolfine 5% nail lacquer Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Amorolfine (as amorolfine hydrochloride) 2.5 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Aciclovir 5% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Penciclovir 10 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Benzyl benzoate 25% application BP Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Carbaryl 0.5% alcoholic lotion (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Malathion 1% cream shampoo (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Malathion 0.5% alcoholic lotion (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Malathion 0.5% liquid Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Malathion 10 mg/mL shampoo Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Phenothrin 0.5% liquid Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely phenothrin 5 milligram/1 gram conventional release cutaneous foam (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Permethrin 1% scalp application Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Chlorhexidine 5% cream BP Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Proflavine cream BPC Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely povidone iodine 50 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Benzalkonium chloride 100 microgram/g and cetrimide 2 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Polynoxylin 100 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium sulfate paste BP (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 10% ointment (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely cetrimide 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Aluminium acetate 6.5 mg/mL cutaneous lotion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Benzalkonium chloride 10 mg/mL cutaneous solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzalkonium chloride 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Cetrimide 10 mg/mL cutaneous solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Cetrimide strong 20% solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Cetrimide strong 40% solution (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Chlorhexidine gluconate+cetrimide 1.5%/15% solution (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Chlorhexidine acetate 1% dusting powder Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely cetrimide 22.5 milligram/1 milliliter and chlorhexidine gluconate 2.25 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely cetrimide 5 milligram/1 milliliter and chlorhexidine gluconate (as chlorhexidine) 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely cetrimide 1.5 milligram/1 milliliter and chlorhexidine gluconate 150 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Chlorhexidine gluconate+cetrimide 1.5%/15% topical liquid sachet (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Chlorhexidine gluconate+cetrimide 0.015%/0.15% topical liquid sachet Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Sodium hypochlorite strong 8% solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Sodium hypochlorite weak 1% solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Sodium hypochlorite topical liquid sachet Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Brilliant green+crystal violet 0.5%/0.5% paint BP Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Crystal violet 0.5% paint BP Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Methylrosanilinium chloride 10 mg/mL cutaneous solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrogen peroxide 6%(20volume) solution BP Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrogen peroxide 12%(40volume) solution BP Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrogen peroxide 30%(100volume) solution BP (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 1.14% dry powder spray Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 7.5% surgical scrub (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 4% skin cleanser solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 2.5% dry powder spray Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine antiseptic 10% solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine alcoholic 10% solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 10% paint Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Silver nitrate 0.5% lotion BP Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely silver nitrate 250 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely silver nitrate 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely silver nitrate 500 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)

    Start Previous Page 5 of 13 Next End

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    POSSIBLY EQUIVALENT TO association reference set

    Back to Start